Variant position: 363 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 473 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KASVLEPGRPASAGNALKGR VPPGDSPPGNGSGPRHINDSP
Mouse KASVLEPGRPASAGNALKGR VPPGDTPPGNGSGPRHINDSP
Rat KASVLEPGRPASAGNALKGR VPPGDTPPGNGSGPRHINDSP
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
27 – 447 Reticulon-4 receptor
346 – 447 Disordered
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth.
Budel S.; Padukkavidana T.; Liu B.P.; Feng Z.; Hu F.; Johnson S.; Lauren J.; Park J.H.; McGee A.W.; Liao J.; Stillman A.; Kim J.E.; Yang B.Z.; Sodi S.; Gelernter J.; Zhao H.; Hisama F.; Arnsten A.F.; Strittmatter S.M.;
J. Neurosci. 28:13161-13172(2008)
Cited for: FUNCTION; INTERACTION WITH MAG; RTN4; OMG; NGFR AND LINGO1; INVOLVEMENT IN SCZD; VARIANTS MET-53; HIS-68; SER-141; HIS-227; MET-263; SER-314; LEU-329 AND MET-363; VARIANTS SCZD TRP-119; HIS-196; CYS-227; GLN-377; TRP-377 AND TRP-399; CHARACTERIZATION OF VARIANTS SCZD TRP-119; HIS-196; GLN-377 AND TRP-377;
A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility.
Kimura H.; Fujita Y.; Kawabata T.; Ishizuka K.; Wang C.; Iwayama Y.; Okahisa Y.; Kushima I.; Morikawa M.; Uno Y.; Okada T.; Ikeda M.; Inada T.; Branko A.; Mori D.; Yoshikawa T.; Iwata N.; Nakamura H.; Yamashita T.; Ozaki N.;
Transl. Psychiatry 7:E1214-E1214(2017)
Cited for: FUNCTION; VARIANTS HIS-68; ASN-259 AND MET-363; INVOLVEMENT IN SCZD; VARIANT SCZD HIS-292; CHARACTERIZATION OF VARIANT SCZD HIS-292;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.